In an era of increased concern about the safety of using erythropoiesis-stimulating agents (ESAs) in patients with chronic kidney disease, findings from the CAPRIT trial have suggested that ESA administration to correct anemia may slow the progression of kidney allograft dysfunction.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lamb, K. E., Lodhi, S. & Meier-Kriesche, H. U. Long-term renal allograft survival in the United States: a critical reappraisal. Am. J. Transplant. 11, 450–462 (2011).
Gouva, C., Nikolopoulos, P., Ioannidis, J. P. & Siamopoulos, K. C. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int. 66, 753–760 (2004).
Kuriyama, S. et al. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. Nephron 77, 176–185 (1997).
Pfeffer, M. A. et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N. Engl. J. Med. 361, 2019–2032 (2009).
Singh, A. K. et al. Correction of anemia with epoetin alfa in chronic kidney disease. N. Engl. J. Med. 355, 2085–2098 (2006).
Choukroun, G. et al. Correction of postkidney transplant anemia reduces progression of allograft nephropathy. J. Am. Soc. Nephrol. http://dx.doi.org/10.1681/ASN.2011060546.
Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am. J. Transplant. 9 (Suppl. 3), S1–S155 (2009).
US Department of Health and Human Services. FDA modifies dosing recommendations for erythropoiesis-stimulating agents. U. S. Food and Drug Administration [online], (2011).
Poge, U. et al. MDRD equations for estimation of GFR in renal transplant recipients. Am. J. Transplant. 5, 1306–1311 (2005).
Poggio, E. D. et al. Assessing glomerular filtration rate by estimation equations in kidney transplant recipients. Am. J. Transplant. 6, 100–108 (2006).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Huang, E., Bunnapradist, S. Does anemia correction delay kidney allograft dysfunction?. Nat Rev Nephrol 8, 196–198 (2012). https://doi.org/10.1038/nrneph.2012.39
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2012.39
This article is cited by
-
Anemia and low-grade inflammation in pediatric kidney transplant recipients
Pediatric Nephrology (2017)